The Good Liar Review by Movies To Watch Tonight
An excellent but slow-moving film that draws the viewer deeper into what appears to be a more sinister outcome.
The acting is superb and that’s what creates such an excellent film. The movie stars Helen Mirren, Ian McKellen, Russell Tovey, Jim Carter. Directed by Bill Condon. Based on the novel by Nicholas Searle. Screenplay by Jeffrey Hatcher. Released in 2019.
The Good Liar is an excellent study of the depths of human psychology and manipulative powers. A study of sheer revenge that may take decades to come to fruition.
The novel is excellent and screenplay wonderfully put together. The direction is outstanding. The acting, novel, screenplay and directing come full circle in The Good Liar to not only complement each other but to captivate the audience and keep them engaged throughout the 1 hour and 49 minutes.
Movies To Watch Tonight Final Verdict
The movie is slow which is what draws and captivates viewers. It takes its time unveiling the truth behind the lies, in The Good Liar. The film had we here at Movies To Watch Tonight in goose bumps by the end, not just in the excellence of the actors and the writing and directing but in the movie plot itself. The Good Liar is well worth the 1 hour and 49 minutes spent. There is little that cannot be done with this in the future.
Frequently Asked Questions
Ornare quam viverra orci sagittis eu volutpat odio. Viverra tellus in hac habitasse platea dictumst vestibulum. Senectus et netus et malesuada fames ac turpis egestas. Amet venenatis urna cursus eget nunc. Tempus imperdiet nulla malesuada pellentesque elit eget gravida cum.
Curabitur vitae nunc sed velit dignissim sodales ut eu sem. Egestas integer eget aliquet nibh praesent tristique. Aliquam malesuada bibendum arcu vitae elementum curabitur vitae.
Curabitur vitae nunc sed velit dignissim sodales ut eu sem. Egestas integer eget aliquet nibh praesent tristique. Aliquam malesuada bibendum arcu vitae elementum curabitur vitae.
Curabitur vitae nunc sed velit dignissim sodales ut eu sem. Egestas integer eget aliquet nibh praesent tristique. Aliquam malesuada bibendum arcu vitae elementum curabitur vitae.
Curabitur vitae nunc sed velit dignissim sodales ut eu sem. Egestas integer eget aliquet nibh praesent tristique. Aliquam malesuada bibendum arcu vitae elementum curabitur vitae.
Tempor id eu nisl nunc mi ipsum faucibus. Gravida arcu ac tortor dignissim convallis aenean et tortor. Volutpat lacus laoreet non curabitur. Ullamcorper malesuada proin libero nunc.
Curabitur vitae nunc sed velit dignissim sodales ut eu sem. Egestas integer eget aliquet nibh praesent tristique. Aliquam malesuada bibendum arcu vitae elementum curabitur vitae.
Curabitur vitae nunc sed velit dignissim sodales ut eu sem. Egestas integer eget aliquet nibh praesent tristique. Aliquam malesuada bibendum arcu vitae elementum curabitur vitae.
Curabitur vitae nunc sed velit dignissim sodales ut eu sem. Egestas integer eget aliquet nibh praesent tristique. Aliquam malesuada bibendum arcu vitae elementum curabitur vitae.
Curabitur vitae nunc sed velit dignissim sodales ut eu sem. Egestas integer eget aliquet nibh praesent tristique. Aliquam malesuada bibendum arcu vitae elementum curabitur vitae
There is a full page of stuff thieradsflfl;kpf’apsp’;fslf’p; p k gfk’ sfk’pk
[kfp[
‘sp;pflkpsdfp
[
There is a full page of stuff
There is a full page of stuff
There is a full page of stuff
| There | is something | here for you |
Johnson and Johnson Stock (JNJ) released better than expected earnings this morning. They reported $2.68 per share on revenue of $24.7 billion, well ahead of estimates of $2.51 per share on revenue of $23.7 billion. The company said it expects 2023 earnings of $10.60 to $10.70 per share on revenue of $97.90 billion to $98.90 billion which is a slightly increase over their prior estimates. The stock though fell as investors remain concerned about the lawsuits JNJ is currently facing.
I think the stock will hold up and I would own shares at $155 or lower if assigned. This trade is out to May 19 expiry.
Johnson and Johnson Stock (JNJ)
TRADE SUMMARY: Credit Put Spread
Equity: Johnson and Johnson Stock (JNJ)
Approx Price At Entry: $161.00
Expiry: May 19 2023
Next Earnings: NA
Potential Profit: $776.00
Potential Return: 5.2%
Approx. Percent of Protection: 3.7%
TRADE DETAILS:
Short Puts: Sold 10 put contracts for May 19 2023 expiry at the $155.00 put strike for an average of $0.866 = $866.00
Long Puts: Bought 10 put contracts for May 19 2023 expiry at the $140.00 put strike for $0.09 = ($90.00)
Spread Details: This forms a $15.00 credit put spread returning 5.2% earning $776.00 if held to expiry on May 19 2023
Buy To Close Early Offer: I am offering $0.35 to start and will reduce that amount as the trade moves toward expiry on May 19 2023
TRADE STATS:
Put Strike Sold: $155.00
Potential Profit: $776.00
Potential Return: 5.2%
Credit Put Spread Size $15.00
Approx. Percent Of Protection: 3.7%
Equity Would Have To Fall To Reach Short Put: $6.00
Capital In Use: $15,000.00